The best indicator for Incyte (INCY)
We backtested 382 indicators across daily, weekly and hourly charts on real Incyte (INCY) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Where Incyte (INCY) stands
Computed from our own daily OHLCV history, not quoted from a third party. Moving averages use closing prices; "52-week" is the last 252 trading sessions.
Relative Volume Spike
On the daily chart, this is the strongest risk-adjusted edge we found for Incyte (INCY) over ~32.5 years — beating buy-and-hold by 3.5% CAGR.
Incyte (INCY) on the daily chart
The timeframe our backtest found best for this asset. The chart is live market data; the results above are hypothetical and historical.
Chart by TradingView. Loading it contacts tradingview.com, which may set its own cookies — see our privacy policy.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for Incyte (INCY) — trailing buy-and-hold by 2.2% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Relative Volume Spike ✓ | Daily | 16.6% | 0.66 | -63.2% | 50.8% | 191 | 3.5% |
| 2 | Coppock Curve ✓ | Daily | 19.8% | 0.63 | -75.2% | 40.7% | 194 | 6.7% |
| 3 | Linear Regression Slope ✓ | Daily | 18.5% | 0.61 | -82.3% | 40.2% | 199 | 5.4% |
| 4 | Squeeze Momentum ✓ | Daily | 16.0% | 0.61 | -51.9% | 44.5% | 416 | 3.0% |
| 5 | Correlation Trend ✓ | Daily | 18.5% | 0.61 | -82.3% | 40.2% | 199 | 5.4% |
| 6 | Supertrend (7,2) ✓ | Daily | 18.6% | 0.61 | -73.4% | 41.4% | 191 | 5.5% |
| 7 | TEMA 20/50 Cross | Daily | 18.3% | 0.6 | -75.0% | 43.3% | 171 | 5.2% |
| 8 | SMA 10/40 Cross | Daily | 17.4% | 0.58 | -82.8% | 43.2% | 125 | 4.3% |
| 9 | Hull MA 20/80 Cross ✓ | Daily | 17.7% | 0.58 | -80.1% | 44.8% | 183 | 4.6% |
| 10 | Hull MA 100 Trend | Daily | 16.1% | 0.57 | -71.2% | 40.7% | 231 | 3.0% |
| 11 | Zero-Lag LSMA | Weekly | 17.3% | 0.57 | -80.0% | 48.6% | 109 | 4.4% |
| 12 | SMA 10/30 Cross | Daily | 16.3% | 0.56 | -83.0% | 37.0% | 154 | 3.2% |
| 13 | Supertrend Fast (10,2) ✓ | Daily | 16.2% | 0.56 | -76.0% | 40.0% | 195 | 3.1% |
| 14 | ZLEMA 100 Trend | Daily | 15.5% | 0.56 | -68.7% | 36.9% | 282 | 2.5% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
What it would take to beat buy & hold on Incyte (INCY)
71 of 682 tested setups beat buy-and-hold on Incyte (INCY) outright. Another 31 could get there with leverage they would survive — but 53 would be liquidated by their own drawdown before they caught it.
| Indicator | Beats B&H unlevered | Leverage needed | Leverage survived |
|---|---|---|---|
| WaveTrend (8/6/4) | 2 | none needed | 2.26× |
| True Strength Index | 2 | none needed | 2.12× |
| Percentage Price Osc. | 2 | none needed | 1.77× |
| Stochastic Momentum Index | 2 | none needed | 2.26× |
| Laguerre RSI | 2 | none needed | 2.23× |
| Connors RSI | 2 | none needed | 3.59× |
Out-of-sample, costs included. A setup is only listed if the leverage it needs is less than the leverage its own worst drawdown survives — when it isn't, no amount of leverage gets there. Volatility drag isn't modelled, so these are the optimistic case. Every indicator, ranked this way
For Incyte (INCY), Relative Volume Spike on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when Incyte’s signal flips
We track Incyte daily. Its backtested best indicator, Relative Volume Spike (Daily), is flat right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.